Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

CLOTRIMAZOLE

All products: general benefit

Other products in the same Health Canada class (G01A) — coverage varies; not interchangeable

  • Nystatin (Mycostatin): general benefit, Not a benefit
  • Terconazole (Terazol 7): general benefit, Not a benefit

Canesten 1 Comfortab Combi-Pak · DIN 02264102 · 500mg & 1% · tablet & Cr

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Canesten 1 Comfortab Combi-Pak · DIN 02264102 Manufacturer: Bayer Inc., Consumer Care Division; listing date 2007-01-02 Health Canada: Marketed since 2023-02-21 · brand CANESTEN COMBI 1 DAY · ATC G01AF02 CLOTRIMAZOLE · form Cream, Kit, Vaginal tablet · route Vaginal, Topical · ingredients CLOTRIMAZOLE 500 MG/VTAB, CLOTRIMAZOLE 1 %/W/W · company Bayer inc · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Canesten 1 Comfortab Combi-Pak: Formulary list price $12.0800/unit (unit not stated in source; not the patient's cost)

Ministry pays: $12.0800 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74952 · Verify on the e-Formulary ↗ (DIN 02264102)

Source record
DIN 02264102: Canesten 1 Comfortab Combi-Pak Raw flags: sec3=Y Item: 840408035; group id 818; item number 1998; lccId None; manufacturer id BAY Source form: Tab & Cr; strength: 500mg & 1% Recorded listing: General benefit Source prices (unrounded): $12.0800; ministry $12.0800 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02264102 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74952
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02264102
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (84:04:08 Fungicides) and how they are covered

Matched class: 84:04:08 Fungicides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: MICONAZOLE NITRATE, TERBINAFINE HCL Some products covered without a code (check the product listing): KETOCONAZOLE, NYSTATIN, TERCONAZOLE 84:04:08 Fungicides

NYSTATIN

· 7 products · Listed, not a benefit (3), General benefit (4) · strengths: 100000U/g, 25000U/g · Cr, Oint, Vag Cr

TERCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.4% · Vag Cr

KETOCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Cr

MICONAZOLE NITRATE

· 1 products · General benefit · strengths: 2% · Cr

TERBINAFINE HCL

· 1 products · General benefit · strengths: 1% · Cr

FLUCONAZOLE

· 8 products · Limited Use, codes 235 · strengths: 150mg · Cap

CICLOPIROX

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8% W/W · Top Sol

CLOTRIMAZOLE & BETAMETHASONE DIPROPIONATE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% w/w & 0.05% w/w · Top Cr Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 84:04:08
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Clotrimaderm Vaginal 6 (clotrimazole) is indicated for the 6-day treatment of vaginal candidiasis. Clotrimaderm Vaginal 3 (clotrimazole) is indicated for the 3-day treatment of vaginal candidiasis. 1.1 Pediatrics Pediatrics (>12 years of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of Clotrimazole in pediatric patients (>12 years of age) has been established. Therefore, Health Canada has authorized an indication for pediatric (>12 years of age) use. https://pdf.hres.ca/dpd_pm/00081078.PDF PM date: July 16, 2025 Source product: CLOTRIMADERM VAGINAL 6; DIN 00812366; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.